Heparin elevates circulating soluble fms-like tyrosine kinase-1 immunoreactivity in pregnant women receiving anticoagulation therapy

Victor A Rosenberg, Irina A Buhimschi, Charles J Lockwood, Michael J Paidas, Antonette T Dulay, Wenda Ramma, Sonya S Abdel-Razeq, Guomao Zhao, Shakil Ahmad, Asif Ahmed, Catalin S Buhimschi

Research output: Contribution to journalArticlepeer-review

Abstract

Alterations in circulating levels of pro- and antiangiogenic factors have been associated with adverse pregnancy outcomes. Heparin is routinely administered to pregnant women, but without clear knowledge of its impact on these factors.
Original languageEnglish
Pages (from-to)2543-53
Number of pages11
JournalCirculation
Volume124
Issue number23
DOIs
Publication statusPublished - 2011

Fingerprint

Dive into the research topics of 'Heparin elevates circulating soluble fms-like tyrosine kinase-1 immunoreactivity in pregnant women receiving anticoagulation therapy'. Together they form a unique fingerprint.

Cite this